Company profile: Roche
1.1 - Company Overview
Company description
- Provider of pharmaceuticals and in-vitro diagnostics, including diagnostic tests and instruments for cancer, diabetes, and infectious diseases; develops medicines for oncology, neurology, virology, inflammation, metabolism, CNS, ophthalmology, immunology, and transplantation; offers digital health solutions for virtual care, decision support, and self-monitoring, plus diabetes management devices and services.
Products and services
- Diagnostic Instruments: Roche fabricates laboratory-scale diagnostic instruments for analyzing patient samples, spanning small devices for clinics to large systems for laboratories, supporting detection of cancer, diabetes, and infectious diseases
- In-Vitro Diagnostics: Roche delivers in-vitro diagnostic tests using blood or tissue samples to detect cancer, diabetes, and infectious diseases, enabling clinical detection and patient monitoring
- Pharmaceuticals: Roche develops chronic-disease-focused medicines for oncology, neurology, infectious diseases, ophthalmology, and transplantation, addressing life-threatening conditions across virology, inflammation, metabolism, CNS, and immunology
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Roche
AES Chemunex
HQ: France
Website
- Description: Provider of conventional and novel culture media, rapid microbiology testing methods, laboratory instruments, and cytometry for microorganism detection, serving applications in the food, pharmaceutical, and cosmetic industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AES Chemunex company profile →
TriVirix
HQ: United States
Website
- Description: Provider of U.S.-based manufacturing and design for electro-mechanical, medical, diagnostic, analytical, and life-science devices, offering ribo printers, point-of-care blood testing analyzers, volumetric infusion pumps, and vital sign or conscious sedation monitors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TriVirix company profile →
DCS Diagnostics
HQ: Germany
Website
- Description: Provider of diagnostic devices as a pharmaceutical firm, specializing in the sale and development of devices for human use.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DCS Diagnostics company profile →
Gold Standard Diagnostics
HQ: United States
Website
- Description: Provider of products, services, and consulting for the diagnostic and medical communities, partnering with reagent and equipment manufacturers worldwide to deliver innovative, cost-effective diagnostic solutions for clinical and hospital laboratories.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gold Standard Diagnostics company profile →
Abraxis
HQ: Trinidad and Tobago
Website
- Description: Provider of rapid test kits and related products for environmental, water quality, food/agriculture, and life sciences, including ELISA, lateral flow, and magnetic particle assay kits; standards and QC materials (certified reference materials and check samples); lab testing equipment (automated analyzers and manual test strip readers); AbraMag magnetic beads; and BACGro dehydrated and prepared culture media.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Abraxis company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Roche
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Roche
2.2 - Growth funds investing in similar companies to Roche
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Roche
4.2 - Public trading comparable groups for Roche
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →